Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wolff

Showing results (811-820 of 973) with videos related to

Pageof 98
Sort By:
American Journal of Clinical Oncology|March 31, 2016
Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation TherapyIn J Park, Y Nancy You, John M Skibber, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2025
Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Preliminary Placebo-Controlled, Randomized, Double-Blind TrialSriram Yennurajalingam, Vicente Valero, Brandon G Smalgo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitorsFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Annals of Surgical Oncology|October 30, 2014
Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancerChristina L Roland, Anthony D Yang, Matthew H G Katz, et al.
Journal of Medical Economics|March 17, 2023
Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving <i>reldesemtiv</i> or placebo in FORTITUDE-ALSPaulos Gebrehiwet, Lisa Meng, Stacy A Rudnicki, et al.
Journal of the American College of Cardiology|September 19, 2003
Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonistEric N Prystowsky, Imran Niazi, Anne B Curtis, et al.
Annals of Surgical Oncology|September 10, 2015
The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative TherapyChristina L Roland, Matthew H G Katz, Ching-Wei D Tzeng, et al.
Lancet (London, England)|August 23, 2011
Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man studyJohn R Teerlink, Cyril P Clarke, Khalil G Saikali, et al.
Oral Diseases|November 26, 2015
World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunctionA Villa, A Wolff, N Narayana, et al.
The Oncologist|August 10, 2022
Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center ExperienceVictoria Serpas Higbie, Jane Rogers, Hyunsoo Hwang, et al.
Pageof 98

Showing results (811-820 of 973) with videos related to

Sort By:
Pageof 98
American Journal of Clinical Oncology|March 31, 2016
Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation TherapyIn J Park, Y Nancy You, John M Skibber, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2025
Physical Activity and Dexamethasone for Cancer-Related Fatigue: A Preliminary Placebo-Controlled, Randomized, Double-Blind TrialSriram Yennurajalingam, Vicente Valero, Brandon G Smalgo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2012
PIK3CA/PTEN mutations and Akt activation as markers of sensitivity to allosteric mTOR inhibitorsFunda Meric-Bernstam, Argun Akcakanat, Huiqin Chen, et al.
Annals of Surgical Oncology|October 30, 2014
Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancerChristina L Roland, Anthony D Yang, Matthew H G Katz, et al.
Journal of Medical Economics|March 17, 2023
Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving <i>reldesemtiv</i> or placebo in FORTITUDE-ALSPaulos Gebrehiwet, Lisa Meng, Stacy A Rudnicki, et al.
Journal of the American College of Cardiology|September 19, 2003
Termination of paroxysmal supraventricular tachycardia by tecadenoson (CVT-510), a novel A1-adenosine receptor agonistEric N Prystowsky, Imran Niazi, Anne B Curtis, et al.
Annals of Surgical Oncology|September 10, 2015
The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative TherapyChristina L Roland, Matthew H G Katz, Ching-Wei D Tzeng, et al.
Lancet (London, England)|August 23, 2011
Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man studyJohn R Teerlink, Cyril P Clarke, Khalil G Saikali, et al.
Oral Diseases|November 26, 2015
World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunctionA Villa, A Wolff, N Narayana, et al.
The Oncologist|August 10, 2022
Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center ExperienceVictoria Serpas Higbie, Jane Rogers, Hyunsoo Hwang, et al.
Pageof 98